Apoptosis-inducing effects of melissa officinalis L. essential oil in glioblastoma multiforme cells

Cancer Investigation

Volumn 32, Issue 6, 2014, Pages 226-235

  De Queiroz, Rafaela Muniz ^a   Takiya, Christina Maeda ^a   Guimarães, Lívia Paes Tavares Pacheco ^a   Rocha, Gleice Da Graça ^a   Alviano, Daniela Sales ^a   Blank, Arie Fitzgerald ^b   Alviano, Celuta Sales ^a   Gattass, Cerli Rocha ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Chemotherapy; Citral; Gliobastoma multiforme; Melissa officinali essential oil

Indexed keywords

CASPASE 3; CISPLATIN; CITRAL; DOXORUBICIN; ESSENTIAL OIL; MELISSA OFFICINALIS EXTRACT; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; REACTIVE OXYGEN METABOLITE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

CHEMOTHERAPY; CITRAL; GLIOBASTOMA MULTIFORME; MELISSA OFFICINALI ESSENTIAL OIL;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; DNA FRAGMENTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MELISSA; MONOTERPENES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OILS, VOLATILE; REACTIVE OXYGEN SPECIES;

EID: 84902206116     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.905587     Document Type: Article

References (31)

1. de SousaAC, AlvianoDS, BlankAF, Alves PB, AlvianoCS, Gattass CR. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J Pharm Pharmacol 2004;56:677-681.
2. Hǎncianu M, Aprotosoaie AC, Gille E, Poiatǎ A, Tuchiluş C, Spac A, Stǎnescu U. Chemical composition and in vitro antimicrobial activity of essential oil of Melissa officinalis L. from Romania. Rev Med Chir Soc Med Nat Iasi 2008;112:843-847.
3. Dudai N, Weinstein Y, Krup M, Rabinski T, Ofir R. Citral is a new inducer of caspase-3 in tumor cell lines. Planta Med 2005;71:484-488.
4. Chaouki W, Leger DY, Liagre B, Beneytout JL, Hmamouchi M. Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundam Clin Pharmacol 2009;23:549-556.
5. Fulda S, Debatin KM. Apoptosis pathways in neuroblastoma therapy. Cancer Lett 2003;197:131-135.
6. Mao X, Yu CR, Li WH, Li WX. Induction of apoptosis by shikonin through a ROS/JNKmediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res 2008;18:879-888.
7. Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol 2010;67:279-283.
8. Nishikawa R. Standard therapy for glioblastoma-a review of where we are. Neurol Med Chir (Tokyo) 2010;50:713-719.
9. Decléves X, Fajac A, Lehmann-Che J, Tardy M, Mercier C, Hurbain I, Laplanche JL, Bernaudin JF, Scheeemann JM. Molecular and functional MDR1-Ppg and MRPs expression in human glioblastoma multiforme cell lines. Int J Cancer 2002;98:173-180.
10. Nakagawa T, Ido K, Sakuma T, Takeuchi H, Sato K, Kubota T. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas. Neuropathology 2009;29:379-388.
11. Quezada C, Peigñan L, Segura R, Riquelme F, Melo R, Rojas DZ, Ayach F, San Martín R, Cárcamo JG. Study of resistance to chemotherapy mediated by ABC transporters in biopsies of glioblastoma multiforme. Rev Méd Chil 2011;139:415-424.
12. Alvarez AI, Real R, Pérez M, Mendoza G, Prieto JG, Merino G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci 2010;99:598-617.
13. Rocha GG, Simões M, Lúcio KA, Oliveira RR, Kaplan MAC, Gattass CR. 3β-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression. Invest New Drugs 2012;30:105-113.
14. Wu CP, Calcagno AM, Hladky SB, Ambudkar SV, Barrand MA. Modulatory effects of plant phenols on human multidrugresistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J 2005;272:4725-4740.
15. Rocha GG, SimõesM, Oliveira RR, Kaplan MAC, Gattass CR. 3β-acetyl tormentic acid (3ATA) a novelmodulator of ABCC proteins activity. Int J Mol Sci 2012;13:6757-6771.
16. Mao H, LeBrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastomamultiforme:molecular mechanisms and therapeutic targets. Cancer Invest 2012;30:48-56.
17. NewmanDJ, Cragg GM.Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012;75:311-235.
18. Buhagiar JA, PodestaMT, Wilson AP,MicallefMJ, Ali S.The induction of apoptosis in humanmelanoma, breast and ovarian cancer cell lines using an essential oil extract from the conifer Tetraclinis articulata. Anticancer Res 1999;19:5435-5443.
19. Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, Fang YT, Woolley C, Young G, Lin HK. Boswellia sacra essential oil induces tumor cell specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement Altern Med 2011;11:129-142.
20. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004;7:97-110.
21. Zhang WB,Wang Z, Shu F, Jin YH, Liu HY,Wang QJ, Yang Y. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J Biol Chem 2010;285:40461-40471.
22. Abe T, Mori T, Wakabayashi Y, Nakagawa M, Cole SP, Koike K, Kuwano M, Hori S. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy. J Neurooncol 1998;40:11-18.
23. Jin F, Zhao L, Guo YJ, Zhao WJ, Zhang H, Wang HT, Shao T, Zhang SL,Wei YJ, Feng J, Jiang XB, Zhao YY. Influence of etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells. Brain Res 2010;1336:103-111.
24. Oliva CR, Moellering DR, Gillespie GY, Corinne E, Griguer CE. Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production. PlosOne 2011;6:1-10, e24665.
25. Benyahia B, Huguet S, Declèves X, Mokhtari K, Crinière E, Bernaudin JF, Scherrmann JM, Delattre JY. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol 2004;66:65-70.
26. Garrido W, Muñoz M, San Martín R, Quezada C. FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1. Biochem Biophys Res Commun 2011;411:62-68.
27. Peigñan L, Garrido W, Segura R, Melo R, Rojas D, Cárcamo JG, SanMartín R, Quezada C. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro. Neurochem Res 2011;36:1397-1406.
28. Mesa-Arango AC, Montiel-Ramos J, Zapata B, Durán C, Betancur-Galvis L, Stashenko E. Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (mill.) N.E. Brown: composition, cytotoxicity and antifungal activity. Mem Inst Oswaldo Cruz 2009;104:878-884.
29. Tatebe S, Sinicrope FA, Kuo MT. Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun 2002;290:1427-1433.
30. Lo LY, Wang W. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chem Biol Interact 2013;205:188-197.
31. Darefsky AS, King Jr., JT, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries. Cancer 2012;118:2163-2172.